MSD (Belgium)

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.2147/copd.s454905 Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
https://doi.org/10.1016/j.pupt.2008.01.009 MK-0873, a PDE4 inhibitor, does not influence the pharmacokinetics of theophylline in healthy male volunteers
https://doi.org/10.1016/j.bone.2012.08.035 Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5year results of a phase 2 trial
https://doi.org/10.1080/13696998.2021.1937188 Cost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US – updated analyses with additional trial follow-up
https://doi.org/10.1117/1.jmm.23.4.043001 Rectification of extreme ultraviolet lithography patterns by directed self-assembly: a roughness and defectivity study
https://doi.org/10.3168/jds.2023-24218 Associations of serostatus upon arrival with clinical respiratory disease, lung consolidation, and growth in veal calves
https://doi.org/10.3899/jrheum.2024-0223 Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies
https://doi.org/10.36469/9801 Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model
https://doi.org/10.12688/wellcomeopenres.16885.2 Gastroenteritis Rehydration Of children with Severe Acute Malnutrition (GASTROSAM): A Phase II Randomised Controlled trial: Trial Protocol
https://doi.org/10.1007/s12325-025-03144-4 Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment Comparison
https://doi.org/10.3389/fgeed.2025.1568072 Recent developments, challenges and opportunities in genome editing for crop science from a societal perspective
https://doi.org/10.3389/fdgth.2025.1567624 Standards in sync: five principles to achieve semantic interoperability for TRUE research for healthcare
https://doi.org/10.1007/s40487-025-00357-z The Health Impact of Using Anti-PD-1 Agents to Treat Early-Stage Cancer in Belgium
https://doi.org/10.1016/j.jgar.2022.02.006 Discrete choice experiment to investigate preferences for incentives to promote antimicrobial research and development
https://doi.org/10.1016/j.jval.2023.03.100 CO26 Impact in Health Outcomes of Anti-PD(L)1 Inhibitors to Treat Early-Stage Cancers in Belgium
https://doi.org/10.55563/clinexprheumatol/7sr1ni Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studie
https://doi.org/10.1080/13696998.2024.2329022 Cost effectiveness of pembrolizumab plus lenvatinib compared with chemotherapy for treating previously treated advanced endometrial cancer in Sweden
https://doi.org/10.1111/cts.70331 Safety and Pharmacokinetics of MK ‐8527 in Adults Without HIV
https://doi.org/10.1111/jerd.13356 The Punch Graft Technique: A Simplified Protocol for Three‐Dimensional Peri‐Implant Soft and/or Hard Tissue Augmentation in a Single Step
https://doi.org/10.1177/09622802251387456 Using inverse probability of censoring weighting to estimate hypothetical estimands in clinical trials: Should we implement stabilisation, and if so how?
https://doi.org/10.1016/j.maturitas.2003.12.012 Patients with osteoporosis prefer once weekly to once daily dosing with alendronate
https://doi.org/10.1016/s0149-2918(00)83062-3 Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension
https://doi.org/10.1038/clpt.1985.136 Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa
https://doi.org/10.1007/s00228-005-0907-8 Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin
https://doi.org/10.1177/00912709922007958 Pharmacokinetics of Intrvenous Alendronate
https://doi.org/10.1111/j.1463-1326.2007.00725.x Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus*
https://doi.org/10.1007/s00228-006-0211-2 The effect of MK-0524, a prostaglandin D2 receptor antagonist, on prostaglandin D2-induced nasal airway obstruction in healthy volunteers
https://doi.org/10.1097/00001888-200102000-00018 A Multiple-station Test of the Teaching Skills of General Practice Preceptors in Flanders, Belgium
https://doi.org/10.1016/j.neuroimage.2012.11.053 Evaluation of [18F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human
https://doi.org/10.2967/jnumed.113.122515 11C-MK-8278 PET as a Tool for Pharmacodynamic Brain Occupancy of Histamine 3 Receptor Inverse Agonists
https://doi.org/10.1185/03007990802667937 Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis.
https://doi.org/10.1185/030079905x46304 Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting β2‐agonists: addition of montelukast in an open-label pilot study
https://doi.org/10.1002/pds.1434 Retracted:A quantitative approach to benefit-risk assessment of medicines — part 2: the practical application of a new model
https://doi.org/10.3109/09537104.2011.604806 A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel
https://doi.org/10.1177/0269881111415731 The effects of TPA023, a GABAAα2,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol
https://doi.org/10.1007/s00431-016-2781-z Moving toward a paradigm shift in the regulatory requirements for pediatric medicines
https://doi.org/10.1186/s12944-015-0037-y Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey
https://doi.org/10.1093/rheumatology/keab233 The burden of psoriatic arthritis in the biologics era: data from the Belgian Epidemiological Psoriatic Arthritis Study
https://doi.org/10.1111/1756-185x.13526 Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO‐VADIS study, a large, prospective real‐life cohort
https://doi.org/10.1186/1129-2377-14-s1-p224 PET imaging in healthy subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy
https://doi.org/10.1136/annrheumdis-2012-eular.2239 THU0274 Double-blind, placebo-controlled, 28-week trial of efficacy and safety of infliximab plus naproxen vs naproxen alone in patients with early, active axial spondyloarthritis treated with a submaximal dose of NSAIDS: Preliminary results of INFAST part I
https://doi.org/10.1117/12.2086160 Toward high-performance quality meeting IC device manufacturing requirements with AZ SMART DSA process
https://doi.org/10.1111/dom.12059 The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid‐lowering treatment strategies in diabetic subjects with and without metabolic syndrome
https://doi.org/10.1159/000052143 Comparison of Preference for Rizatriptan 10-mg Wafer versus Sumatriptan 50-mg Tablet in Migraine
https://doi.org/10.1016/0378-1119(89)90382-x Cloning and expression of cDNA encoding antistasin, a leech-derived protein having anti-coagulant and anti-metastatic properties
https://doi.org/10.1128/aac.47.4.1439-1442.2003 Tissue Penetration by Ertapenem, a Parenteral Carbapenem Administered Once Daily, in Suction-Induced Skin Blister Fluid in Healthy Young Volunteers
https://doi.org/10.1038/clpt.1982.223 Timolol and propranolol: Bioavailability, plasma concentrations, and beta blockade
https://doi.org/10.1111/j.1742-1241.2008.01697.x Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study
https://doi.org/10.1016/s0090-4295(99)00130-2 Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years
https://doi.org/10.1023/a:1015886415210 Applications of oxygen polarography to drug stability testing and formulation development: solution-phase oxidation of hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.
https://doi.org/10.1186/1752-1505-2-15 Providing HIV care in the aftermath of Kenya's post-election violence Medecins Sans Frontieres' lessons learned January – March 2008
https://doi.org/10.1177/0091270004268129 The Effects of Modifying In Vivo Cytochrome P450 3A (CYP3A) Activity on Etoricoxib Pharmacokinetics and of Etoricoxib Administration on CYP3A Activity
https://doi.org/10.1007/s00259-010-1395-3 Erratum to: Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain
https://doi.org/10.1007/s00397-010-0431-3 Thermo-rheological behavior of model protein–polysaccharide mixtures
https://doi.org/10.1002/acr.22371 Patient and Physician Expectations of Add‐On Treatment With Golimumab for Rheumatoid Arthritis: Relationships Between Expectations and Clinical and Quality of Life Outcomes
https://doi.org/10.1186/1476-511x-11-18 Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study
Translational studies with [11C]MK-3168, a PET tracer for fatty acid amide hydrolase (FAAH)
Clinical and quality of life improvements with golimumab or infliximab in a real-life ankylosing spondylitis population: the QUO-VADIS study.
https://doi.org/10.3109/09537104.2011.565433 The effects of laropiprant, a selective prostaglandin D2receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin
https://doi.org/10.1177/2168479017753129 Clinical Trial Results Summary for Laypersons: A User Testing Study
https://doi.org/10.1186/1476-511x-12-103 Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects
https://doi.org/10.1080/17843286.2018.1539203 Frequency and predictors of cholesterol target attainment in patients with stable coronary heart disease in Belgium: results from the Dyslipidemia International Study II (DYSIS II CHD)
https://doi.org/10.3390/healthcare10091600 Making Sure That Orphan Incentives Tip the Right Way in Europe
https://doi.org/10.1080/14760584.2023.2157266 Estimating the lifetime cost of vaccination in 23 European Countries: a modeling study
https://doi.org/10.1016/j.clinthera.2018.03.002 Antiviral Activity, Safety, and Tolerability of Multiple Ascending Doses of Elbasvir or Grazoprevir in Participants Infected With Hepatitis C Virus Genotype-1 or -3
https://doi.org/10.1002/cap.10264 The expanded mesh free gingival graft: A novel approach to increase the width of keratinized mucosa
https://doi.org/10.1177/25158163231191582 Pharmacokinetic and pharmacodynamic assessments of atogepant in healthy male adults: Results from phase 1 studies
https://doi.org/10.1117/12.3010505 Directed self-assembly: PS-b-PMMA materials readiness and high-chi platforms for extended geometry scaling
https://doi.org/10.1117/12.2659716 Negative-tone resists for EUV lithography
https://doi.org/10.1016/j.bone.2012.02.127 Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5year results of a phase 2 trial
https://doi.org/10.1007/s002280050736 Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans
https://doi.org/10.1038/clpt.1982.125 Effects of enalapril, a new converting enzyme inhibitor, in hypertension
https://doi.org/10.1016/0140-6736(92)92092-t Simvastatin use in children
https://doi.org/10.1128/aac.30.5.781 In vitro activity of LY146032 against staphylococci, streptococci, and enterococci
https://doi.org/10.1128/aac.29.2.193 In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones
https://doi.org/10.1002/(sici)1520-6777(1999)18:1<17::aid-nau4>3.0.co;2-m Repeated pressure-flow studies in the evaluation of bladder outlet obstruction due to benign prostatic enlargement
https://doi.org/10.1177/0091270006297007 Multiple‐Dose Administration of Sitagliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Does Not Alter the Single‐Dose Pharmacokinetics of Rosiglitazone in Healthy Subjects
https://doi.org/10.1038/clpt.1982.178 Sulindac disposition when given once and twice daily
https://doi.org/10.1128/aac.42.2.223 Effect of Fluconazole on Indinavir Pharmacokinetics in Human Immunodeficiency Virus-Infected Patients
https://doi.org/10.1007/bf02854844 Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin II receptor antagonists, losartan and valsartan
https://doi.org/10.1016/s0161-6420(78)35611-6 Slow-Release Artificial Tears and the Treatment of Keratitis Sicca
https://doi.org/10.1111/j.1365-2036.1991.tb00531.x Famotidine (20 mg) b.d. relieves gastrooesophageal reflux symptoms in patients without erosive oesophagitis
https://doi.org/10.1016/s0149-2918(03)80133-9 Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension
https://doi.org/10.1023/a:1015946114321 The Effects of Carbidopa Dose and Time and Route of Administration on Systemic L-Dopa Levels in Rats
https://doi.org/10.1016/s0003-9098(25)01348-7 Interaction of genotype, egg shell conductance and dietary T3 supplementation in the development of heart failure syndrome and ascites in broiler chickens
https://doi.org/10.1159/000210962 Clinical and Biochemical Effects of an Oral Leukotriene Biosynthesis Inhibitor (MK886) in Psoriasis
https://doi.org/10.1016/j.biopsych.2008.01.021 In Vivo Characterization and Dynamic Receptor Occupancy Imaging of TPA023B, an α2/α3/α5 Subtype Selective γ-Aminobutyric Acid–A Partial Agonist
https://doi.org/10.1016/0304-4017(94)00705-h Control of Sarcoptes scabiei var. suis with ivermectin: influence on scratching behaviour of fattening pigs and occurrence of dermatitis at slaughter
https://doi.org/10.1021/tx034117n An Evaluation of a Low-Density DNA Microarray Using Cytochrome P450 Inducers
https://doi.org/10.1023/a:1015893231430 Formulation and Optimization of a Modified Microporous Cellulose Acetate Latex Coating for Osmotic Pumps
https://doi.org/10.1046/j.1365-2036.2002.01332.x Effects of enteric‐coated, low‐dose aspirin on parameters of platelet function
https://doi.org/10.1023/a:1015842032164 Stability of the Thrombolytic Protein Fibrolase: Effect of Temperature and pH on Activity and Conformation
https://doi.org/10.1038/clpt.1991.105 Assessment of MK-467, a peripheral α2-adrenergic receptor antagonist, with intravenous clonidine
https://doi.org/10.1185/030079904125004367 Efficacy and safety of simvastatin in Asian and non-Asian coronary heart disease patients: a comparison of the GOALLS and STATT studies
https://doi.org/10.1007/bf02220621 Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man
https://doi.org/10.1152/ajpendo.00527.2015 Linearity of β-cell response across the metabolic spectrum and to pharmacology: insights from a graded glucose infusion-based investigation series
https://doi.org/10.1097/qai.0000000000002834 Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week
https://doi.org/10.1136/annrheumdis-2013-eular.726 THU0198 Patient Evaluations of Autoinjectors for Delivery of Subcutaneous Golimumab for Treatment of Rheumatoid Arthritis
https://doi.org/10.1016/j.bone.2011.03.129 Four-year results of a phase 2 study of the cathepsin K inhibitor odanacatib in postmenopausal women with low bone mineral density: Effects on bone mineral density and bone turnover markers